Studies have shown that eupafolin hampers tumor cell growth, movement, and tubular structure development induced by VEGF bycurbing the VEGFR2 activation, leading to reduced phosphorylation of ERK1/2 and Akt signaling pathways [60]. The gene discussed is MAPK3; the disease is neoplasm.